• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症免疫治疗和疫苗应用的自组装 STING 激活配位纳米粒子。

Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications.

机构信息

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States.

Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.

出版信息

ACS Nano. 2024 Apr 16;18(15):10439-10453. doi: 10.1021/acsnano.3c11374. Epub 2024 Apr 3.

DOI:10.1021/acsnano.3c11374
PMID:38567994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11031738/
Abstract

The cGAS-STING pathway plays a crucial role in innate immune activation against cancer and infections, and STING agonists based on cyclic dinucleotides (CDN) have garnered attention for their potential use in cancer immunotherapy and vaccines. However, the limited drug-like properties of CDN necessitate an efficient delivery system to the immune system. To address these challenges, we developed an immunostimulatory delivery system for STING agonists. Here, we have examined aqueous coordination interactions between CDN and metal ions and report that CDN mixed with Zn and Mn formed distinctive crystal structures. Further pharmaceutical engineering led to the development of a functional coordination nanoparticle, termed the Zinc-Mn-CDN Particle (ZMCP), produced by a simple aqueous one-pot synthesis. Local or systemic administration of ZMCP exerted robust antitumor efficacy in mice. Importantly, recombinant protein antigens from SARS-CoV-2 can be simply loaded during the aqueous one-pot synthesis. The resulting ZMCP antigens elicited strong cellular and humoral immune responses that neutralized SARS-CoV-2, highlighting ZMCP as a self-adjuvant vaccine platform against COVID-19 and other infectious pathogens. Overall, this work establishes a paradigm for developing translational coordination nanomedicine based on drug-metal ion coordination and broadens the applicability of coordination medicine for the delivery of proteins and other biologics.

摘要

cGAS-STING 通路在针对癌症和感染的先天免疫激活中发挥着关键作用,基于环状二核苷酸(CDN)的 STING 激动剂因其在癌症免疫治疗和疫苗中的潜在用途而受到关注。然而,CDN 的有限的类药性需要一种有效的递送到免疫系统的系统。为了解决这些挑战,我们开发了一种用于 STING 激动剂的免疫刺激性递药系统。在这里,我们研究了 CDN 与金属离子之间的水相配位相互作用,并报告说 CDN 与 Zn 和 Mn 混合形成了独特的晶体结构。进一步的药物工程导致了一种功能性配位纳米颗粒的开发,称为锌-锰-CD 纳米颗粒(ZMCP),它是通过简单的水相一锅合成产生的。ZMCP 的局部或系统给药在小鼠中发挥了强大的抗肿瘤功效。重要的是,来自 SARS-CoV-2 的重组蛋白抗原可以在水相一锅合成过程中简单加载。由此产生的 ZMCP 抗原引发了强烈的细胞和体液免疫反应,中和了 SARS-CoV-2,凸显了 ZMCP 作为针对 COVID-19 和其他传染病原体的自佐剂疫苗平台。总的来说,这项工作建立了基于药物-金属离子配位的转化协调纳米医学的发展范式,并拓宽了协调医学在蛋白质和其他生物制剂递送上的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/dc6487580fcc/nihms-1985341-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/b65290487ffb/nihms-1985341-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/7c8eef5369a0/nihms-1985341-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/fc906ae0790b/nihms-1985341-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/c01b3a88a0a7/nihms-1985341-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/37a1439df8a1/nihms-1985341-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/4f54bad8d9eb/nihms-1985341-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/4f38a57441d2/nihms-1985341-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/dc6487580fcc/nihms-1985341-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/b65290487ffb/nihms-1985341-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/7c8eef5369a0/nihms-1985341-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/fc906ae0790b/nihms-1985341-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/c01b3a88a0a7/nihms-1985341-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/37a1439df8a1/nihms-1985341-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/4f54bad8d9eb/nihms-1985341-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/4f38a57441d2/nihms-1985341-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/11031738/dc6487580fcc/nihms-1985341-f0008.jpg

相似文献

1
Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications.用于癌症免疫治疗和疫苗应用的自组装 STING 激活配位纳米粒子。
ACS Nano. 2024 Apr 16;18(15):10439-10453. doi: 10.1021/acsnano.3c11374. Epub 2024 Apr 3.
2
Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.cGAS-STING 免疫调节剂的工程设计与递送及其在癌症和自身免疫性疾病免疫治疗中的应用。
Acc Chem Res. 2023 Nov 7;56(21):2933-2943. doi: 10.1021/acs.accounts.3c00394. Epub 2023 Oct 6.
3
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy.响应性多泡聚合物纳米疫苗,共递送 STING 激动剂和新抗原用于联合肿瘤免疫治疗。
Adv Sci (Weinh). 2022 Aug;9(23):e2201895. doi: 10.1002/advs.202201895. Epub 2022 Jun 16.
4
Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy.环状二核苷酸-锰颗粒增强 STING 激活用于局部和全身癌症金属免疫治疗。
Nat Nanotechnol. 2021 Nov;16(11):1260-1270. doi: 10.1038/s41565-021-00962-9. Epub 2021 Sep 30.
5
STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications.载 STING 激动剂的介孔锰硅纳米颗粒在疫苗中的应用。
J Control Release. 2023 May;357:84-93. doi: 10.1016/j.jconrel.2023.03.036. Epub 2023 Mar 28.
6
Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.基于 T 细胞和 B 细胞的治疗性癌症疫苗的合理设计。
Acc Chem Res. 2022 Sep 20;55(18):2660-2671. doi: 10.1021/acs.accounts.2c00360. Epub 2022 Sep 1.
7
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.载药佐剂癌症疫苗的 MuSyC 给药优化了抗肿瘤反应。
Front Immunol. 2022 Aug 19;13:936129. doi: 10.3389/fimmu.2022.936129. eCollection 2022.
8
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.纳米颗粒递呈改善环状二核苷酸 STING 激动剂的药代动力学特性,为静脉给药开辟治疗窗口。
J Control Release. 2021 Feb 10;330:1118-1129. doi: 10.1016/j.jconrel.2020.11.017. Epub 2020 Nov 12.
9
Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.金属配位纳米诊疗剂通过核苷代谢抑制剂介导,增强 STING 通路激活用于癌症金属免疫治疗。
J Control Release. 2024 Jun;370:354-366. doi: 10.1016/j.jconrel.2024.04.042. Epub 2024 May 3.
10
A trinity STING-activating nanoparticle harnesses cancer cell STING machinery for enhanced immunotherapy.一种三联体STING激活纳米颗粒利用癌细胞的STING机制增强免疫治疗效果。
J Control Release. 2025 Jan 10;377:256-266. doi: 10.1016/j.jconrel.2024.11.035. Epub 2024 Nov 21.

引用本文的文献

1
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions.癌症免疫疗法的进展:历史回顾、当前发展及未来方向。
Mol Cancer. 2025 May 7;24(1):136. doi: 10.1186/s12943-025-02305-x.
2
Progress Update on STING Agonists as Vaccine Adjuvants.作为疫苗佐剂的STING激动剂的进展更新
Vaccines (Basel). 2025 Mar 31;13(4):371. doi: 10.3390/vaccines13040371.
3
Unleashing the Potential of Metal Ions in cGAS-STING Activation: Advancing Nanomaterial-Based Tumor Immunotherapy.释放金属离子在cGAS-STING激活中的潜力:推进基于纳米材料的肿瘤免疫治疗

本文引用的文献

1
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.普罗沙胺可降低 SARS-CoV-2 感染和相关炎症反应。
Proc Natl Acad Sci U S A. 2023 Jul 25;120(30):e2221809120. doi: 10.1073/pnas.2221809120. Epub 2023 Jul 17.
2
STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications.载 STING 激动剂的介孔锰硅纳米颗粒在疫苗中的应用。
J Control Release. 2023 May;357:84-93. doi: 10.1016/j.jconrel.2023.03.036. Epub 2023 Mar 28.
3
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration.
ACS Omega. 2025 Mar 17;10(12):11723-11742. doi: 10.1021/acsomega.4c10865. eCollection 2025 Apr 1.
4
Dual-modality immune nano-activator harnessing Mn⁺ and quercetin to potentiate the cGAS-STING pathway for advanced cancer metalloimmunotherapy.利用锰离子和槲皮素增强cGAS-STING通路用于晚期癌症金属免疫治疗的双模态免疫纳米激活剂
J Nanobiotechnology. 2025 Mar 25;23(1):248. doi: 10.1186/s12951-025-03336-8.
5
Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA.通过递送STING激动剂加突变型KRAS mRNA的脂质纳米颗粒重编程针对胰腺癌转移的耐受性免疫反应。
ACS Nano. 2025 Mar 11;19(9):8579-8594. doi: 10.1021/acsnano.4c14102. Epub 2025 Mar 2.
6
Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment.用于癌症治疗中激活STING的环状二核苷酸的新型修饰和递送方式
Int J Nanomedicine. 2025 Jan 6;20:181-197. doi: 10.2147/IJN.S503780. eCollection 2025.
7
A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer.一种缺氧激活和微环境重塑的纳米平台,用于癌症的多功能成像和增强免疫治疗。
Nat Commun. 2024 Nov 29;15(1):10395. doi: 10.1038/s41467-024-53906-x.
8
Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy.基于水凝胶的原位疫苗接种以实现稳健和持续的 STING 通路激活用于癌症免疫治疗。
ACS Nano. 2024 Oct 29;18(43):29439-29456. doi: 10.1021/acsnano.3c12337. Epub 2024 Oct 15.
9
Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies.用于癌症治疗的智能运载工具:类别、独特作用及治疗策略
Nanoscale Adv. 2024 Jun 20;6(17):4275-4308. doi: 10.1039/d4na00285g. eCollection 2024 Aug 20.
锌环二磷酸腺苷纳米颗粒通过内皮细胞中的干扰素基因刺激蛋白(STING)激活和肿瘤相关巨噬细胞的再激活来靶向并抑制肿瘤。
Nat Nanotechnol. 2022 Dec;17(12):1322-1331. doi: 10.1038/s41565-022-01225-x. Epub 2022 Oct 27.
4
Delivery of STING agonists for adjuvanting subunit vaccines.STING 激动剂在佐剂亚单位疫苗中的递送。
Adv Drug Deliv Rev. 2021 Dec;179:114020. doi: 10.1016/j.addr.2021.114020. Epub 2021 Oct 29.
5
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.MIW815(ADU-S100),一种肿瘤内 STING 激动剂,在晚期/转移性实体瘤或淋巴瘤患者中的 I 期剂量递增试验。
Clin Cancer Res. 2022 Feb 15;28(4):677-688. doi: 10.1158/1078-0432.CCR-21-1963.
6
Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy.环状二核苷酸-锰颗粒增强 STING 激活用于局部和全身癌症金属免疫治疗。
Nat Nanotechnol. 2021 Nov;16(11):1260-1270. doi: 10.1038/s41565-021-00962-9. Epub 2021 Sep 30.
7
Metal-organic frameworks for advanced drug delivery.用于先进药物递送的金属有机框架材料。
Acta Pharm Sin B. 2021 Aug;11(8):2362-2395. doi: 10.1016/j.apsb.2021.03.019. Epub 2021 Mar 13.
8
Frontiers of metal-coordinating drug design.金属配位药物设计前沿
Expert Opin Drug Discov. 2021 May;16(5):497-511. doi: 10.1080/17460441.2021.1851188. Epub 2020 Dec 1.
9
Engineering precision nanoparticles for drug delivery.工程化精准纳米颗粒用于药物递送。
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4.
10
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.锰通过 cGAS-STING 对抗肿瘤免疫反应至关重要,并提高了临床免疫疗法的疗效。
Cell Res. 2020 Nov;30(11):966-979. doi: 10.1038/s41422-020-00395-4. Epub 2020 Aug 24.